Despite this scale, no drug therapies have been approved to treat the condition
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
Wegovy (semaglutide 2.4 mg) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for weight management in adults with obesity or overweight with weight-related comorbidities, as an adjunct to reduced-calorie diet and increased physical activity
Comparative study of intralesional vitamin D3 injection and Candida albicans antigen in treating plantar warts
Our findings strengthen previous research that advocated possible anti-depressant or anxiolytic effects of GLP1-RA and may lead to improved treatment adherence among patients with DM
No, semaglutide requires a valid prescription from licensed healthcare providers, though telehealth options make access easier than ever
